Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Bingley

Showing results (11-20 of 165) with videos related to

Pageof 17
Sort By:
BMJ (Clinical Research Ed.)|March 4, 1989
Incidence of insulin dependent diabetes in England: a study in the Oxford region, 1985-6P J Bingley, E A Gale
Diabetes Care|April 1, 1989
Rising incidence of IDDM in EuropeP J Bingley, E A Gale
Postgraduate Medicine|February 1, 1982
Workup for thyroid disease: a flowchartS M Lazo, L J Bingley
Bailliere'S Clinical Endocrinology and Metabolism|June 1, 1991
Genetics of diabetes. Lessons from family studiesP J Bingley, E A Gale
Diabetes, Obesity & Metabolism|May 30, 2009
Strategies to prevent type 1 diabetesS L Thrower, P J Bingley
Diabetes Care|April 1, 1994
Can we prevent IDDM?E A Gale, P J Bingley
Diabetologia|March 4, 2006
Progression to type 1 diabetes in islet cell antibody-positive relatives in the European Nicotinamide Diabetes Intervention Trial: the role of additional immune, genetic and metabolic markers of riskP J Bingley, E A M Gale,
Journal of Immunology (Baltimore, Md. : 1950)|September 2, 1998
IA-2 (islet cell antigen 512) is the primary target of humoral autoimmunity against type 1 diabetes-associated tyrosine phosphatase autoantigensE Bonifacio, V Lampasona, P J Bingley
Diabetologia|May 22, 2012
Worth the wait: type 1 diabetes prospective birth cohort studies enter adolescenceA J K Williams, P J Bingley
Autoimmunity|November 3, 2004
Validation of autoantibody assays in type 1 diabetes: workshop programmePolly J Bingley, Alistair J K Williams
Pageof 17

Showing results (11-20 of 165) with videos related to

Sort By:
Pageof 17
BMJ (Clinical Research Ed.)|March 4, 1989
Incidence of insulin dependent diabetes in England: a study in the Oxford region, 1985-6P J Bingley, E A Gale
Diabetes Care|April 1, 1989
Rising incidence of IDDM in EuropeP J Bingley, E A Gale
Postgraduate Medicine|February 1, 1982
Workup for thyroid disease: a flowchartS M Lazo, L J Bingley
Bailliere'S Clinical Endocrinology and Metabolism|June 1, 1991
Genetics of diabetes. Lessons from family studiesP J Bingley, E A Gale
Diabetes, Obesity & Metabolism|May 30, 2009
Strategies to prevent type 1 diabetesS L Thrower, P J Bingley
Diabetes Care|April 1, 1994
Can we prevent IDDM?E A Gale, P J Bingley
Diabetologia|March 4, 2006
Progression to type 1 diabetes in islet cell antibody-positive relatives in the European Nicotinamide Diabetes Intervention Trial: the role of additional immune, genetic and metabolic markers of riskP J Bingley, E A M Gale,
Journal of Immunology (Baltimore, Md. : 1950)|September 2, 1998
IA-2 (islet cell antigen 512) is the primary target of humoral autoimmunity against type 1 diabetes-associated tyrosine phosphatase autoantigensE Bonifacio, V Lampasona, P J Bingley
Diabetologia|May 22, 2012
Worth the wait: type 1 diabetes prospective birth cohort studies enter adolescenceA J K Williams, P J Bingley
Autoimmunity|November 3, 2004
Validation of autoantibody assays in type 1 diabetes: workshop programmePolly J Bingley, Alistair J K Williams
Pageof 17